Skip to content

Becton, Dickinson and Company BDX Intangible assets — net

Intangible assets — net at other companies

ICU Medical logo
ICU MedicalICUI
Omnicell logo
OmnicellOMCL
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.CTKB
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$41.7B-14.4%
Enterprise value$55.39B-15.4%
P/E36.6×+5.9×
P/S-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's intangible assets — net?
Becton, Dickinson and Company (BDX) reported intangible assets — net of $8.35B in Q1 2026.
How has Becton, Dickinson and Company's intangible assets — net changed year-over-year?
Becton, Dickinson and Company's intangible assets — net decreased by 17.5% year-over-year, from $10.12B to $8.35B.
What is the long-term trend for Becton, Dickinson and Company's intangible assets — net?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's intangible assets — net has grown at a -7.7% compound annual growth rate (CAGR), from $12.73B to $9.23B.